All under 40s in Briton will be offered an alternative to the Oxford/AstraZeneca vaccine, the Medicines and Healthcare products Regulatory Agency (MHRA) and Joint Committee on vaccination and Immunisation (JCVI) have announced today. The new advise comes after those aged under 30 were given a choice of COVID-19 jab over blood clotting concerns. But the MHRA and JCVI have stressed there are no new safety concerns, especially relating to the second dose of the vaccine.
